Pacer Advisors
ONCE

Pacer Advisors’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Pacer Advisors’s Portfolio ONCE Stock Details ONCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-4,092
Closed -$223K – 1165
2018
Q3 		$223K Buy
+4,092
New +$280K 0.01% 1012
2018
Q1 		– Sell
-950
Closed -$49K – 1177
2017
Q4 		$49K Buy
+950
New +$68.2K ﹤0.01% 1019

Other funds holding ONCE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Pacer Advisors's ONCE Position: Q4 2018 in Review

Pacer Advisors sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2018, closing a stake of 4,092 shares — an estimated $223K sold.

Pacer Advisors first reported a position in ONCE in Q4 2017 and held it in 2 quarters. The position peaked at $223K in Q3 2018. 157 funds tracked by Wall St. Rank hold ONCE as of Q4 2018.

  • Pacer Advisors reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
  • Pacer Advisors sold 4,092 Spark Therapeutics, Inc. Common Stock shares in Q4 2018, an estimated $223K.
  • Pacer Advisors first reported a position in Spark Therapeutics, Inc. Common Stock in Q4 2017 and held it in 2 quarters.
  • Pacer Advisors's Spark Therapeutics, Inc. Common Stock position peaked at $223K in Q3 2018.
  • 157 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2018.

Based on Pacer Advisors's 13F filing for Q4 2018, filed 13 Feb 2019.